Form 4 for URGN UroGen Pharma Ltd.
Accepted 2026-09-09 14:35:46 ET · period of report 2026-09-07 · accession 0001437749-26-029963 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-09 14:35 | 2026-09-07 | URGN | Smith Jason Drew | GC | M - OptEx | — | +3,334 | 54.7K | +6% | — |
| D | 2026-09-09 14:35 | 2026-09-08 | URGN | Smith Jason Drew | GC | S - Sale+OE | $42.54 | -1,519 | 53.1K | -3% | -$64.6K |
| D | 2026-09-09 14:35 | 2026-09-07 | URGN | Smith Jason Drew | GC | M - OptEx | $0.00 | -3,334 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-07 | M | A | 3,334 | — | 54,660 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. |
| 2 | Common | Ordinary Shares | 2026-09-08 | S | D | 1,519 | $42.54 | 53,141 | D | — | — | (F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2026-09-07 | M | D | 3,334 | $0.00 | 0 | D | — · — to — | 3,334 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F3) The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. (F3) The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. |